Form 4: ACM Research Director Sells Shares Under 10b5-1 Plan

ACM Research Director Haiping Dun reported transactions involving Class A Common Stock, including the acquisition of 5,000 shares and the sale of 7,500 shares under a pre-arranged trading plan.

Summary

• Haiping Dun, a Director at ACM Research, Inc. (ACMR), reported a series of stock transactions on May 19, 2026.
• These transactions include the acquisition of 5,000 shares of Class A Common Stock at a price of $5.60 per share.
• Additionally, Dun sold a total of 7,500 shares of Class A Common Stock across multiple transactions at weighted average prices ranging from $63.84 to $67.54.
• These sales were executed under a Rule 10b5-1 trading plan adopted on August 13, 2025.
• Following these transactions, Dun's direct beneficial ownership of Class A Common Stock is 0 shares, while indirect ownership includes 100,000 shares held by the Dun Family GST Trust and 755,090 shares held by the Haiping Dun & Chi-Pin H Dun Revocable Trust.
• A stock option for 5,000 shares, with an exercise price of $5.60, is noted as fully vested and exercisable, with an expiration date of April 22, 2029.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing as neutral to slightly negative due to the significant volume of shares sold by a director, despite the sales being conducted under a pre-arranged 10b5-1 plan.

Positives

• Director Haiping Dun acquired 5,000 shares of Class A Common Stock, indicating continued investment in the company.
• The sales were conducted under a Rule 10b5-1 trading plan, suggesting a pre-determined and structured approach to stock disposition, which can mitigate concerns about insider trading.
• The company has a stock option plan in place, with a vested option for 5,000 shares held by the reporting person.

Negatives

• Director Haiping Dun sold a significant number of shares (7,500) from his direct holdings.
• The weighted average sale price of $63.84 to $67.54 indicates a substantial value realized from these sales.

Risks

• The sale of a large number of shares by a director, even under a 10b5-1 plan, could be interpreted negatively by the market, potentially impacting investor sentiment.
• While not explicitly stated as a risk in this filing, significant insider selling can sometimes precede or coincide with periods of stock price decline or company-specific challenges.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding the company's future performance. It solely reports on past transactions.

Management Comments

• The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 13, 2025.
• The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2), (3), (4), and (5) to this Form 4.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The use of a Rule 10b5-1 plan by a director like Haiping Dun at ACM Research is a common practice to facilitate planned stock sales while adhering to insider trading regulations. The significant volume of sales, however, warrants attention from investors monitoring insider activity within the semiconductor equipment sector.

Stakeholder Impact

• Shareholders: May perceive the director's sales as a negative signal, potentially impacting stock price, despite the 10b5-1 plan.
• Management: The sales may prompt internal discussions on communication strategies regarding insider transactions.
• Employees: Similar to shareholders, employees with stock options or holdings may be influenced by insider selling activity.

Next Steps

• Monitor future Form 4 filings for any further transactions by Haiping Dun or other insiders.
• Observe the market's reaction to these reported sales.

Key Dates

Recommendation

The filing reports routine insider transactions under a 10b5-1 plan, which is a standard compliance mechanism. While the volume of sales by a director warrants attention, the pre-planned nature mitigates immediate concerns about negative company outlook. Therefore, a 'hold' recommendation is appropriate, suggesting investors monitor further developments rather than making immediate trading decisions based solely on this report.

Keywords

ACM Research, ACMR, Form 4, Insider Trading, Stock Sale, Rule 10b5-1, Director Transactions, Class A Common Stock, Beneficial Ownership, Stock Option